Literature DB >> 9892107

High-density screen of human tumor cell lines for homozygous deletions of loci on chromosome arm 8p.

A Levy1, U C Dang, R Bookstein.   

Abstract

Tumor cell-specific homozygous deletions coinciding at a particular genetic location may indicate the inactivation of a nearby tumor suppressor gene. Forty-six human cancer cell lines of prostate, pancreatic, lung, liver, and colon origin were screened for homozygous deletions of 139 expressed sequence tag (EST) and sequence-tagged site (STS) loci spanning the entire short arm of chromosome 8. Only one Southern blot-verified homozygous deletion was detected in this set of cell lines. The deletion, in pancreatic tumor cell line MIA-PaCa-2, encompassed two screening loci, D8S549 and D8S1992, and overlapped another previously described homozygous deletion of band 8p22 in a metastatic prostate cancer specimen. Both deletions entirely removed the candidate tumor suppressor gene N33. These data define a consensus homozygous deletion region in chromosome band 8p22.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9892107     DOI: 10.1002/(sici)1098-2264(199901)24:1<42::aid-gcc6>3.0.co;2-f

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  11 in total

1.  High-resolution physical map and transcript identification of a prostate cancer deletion interval on 8p22.

Authors:  Z H Arbieva; K Banerjee; S Y Kim; S L Edassery; V S Maniatis; S K Horrigan; C A Westbrook
Journal:  Genome Res       Date:  2000-02       Impact factor: 9.043

2.  Genomic-scale comparison of sequence- and structure-based methods of function prediction: does structure provide additional insight?

Authors:  J S Fetrow; N Siew; J A Di Gennaro; M Martinez-Yamout; H J Dyson; J Skolnick
Journal:  Protein Sci       Date:  2001-05       Impact factor: 6.725

3.  SOX7 transcription factor: sequence, chromosomal localisation, expression, transactivation and interference with Wnt signalling.

Authors:  W Takash; J Cañizares; N Bonneaud; F Poulat; M G Mattéi; P Jay; P Berta
Journal:  Nucleic Acids Res       Date:  2001-11-01       Impact factor: 16.971

4.  TUSC3 suppresses glioblastoma development by inhibiting Akt signaling.

Authors:  Zhenfeng Jiang; Mian Guo; Xiangtong Zhang; Lifen Yao; Jia Shen; Guizhen Ma; Li Liu; Liwei Zhao; Chuncheng Xie; Hongsheng Liang; Haiyang Wang; Minwei Zhu; Li Hu; Yuanyuan Song; Hong Shen; Zhiguo Lin
Journal:  Tumour Biol       Date:  2016-05-13

5.  Quantitative detection of TUSC3 promoter methylation -a potential biomarker for prognosis in lung cancer.

Authors:  Uta Duppel; Matthias Woenckhaus; Christian Schulz; Johannes Merk; Wolfgang Dietmaier
Journal:  Oncol Lett       Date:  2016-08-01       Impact factor: 2.967

6.  Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.

Authors:  Judith N Kloth; Jan Oosting; Tom van Wezel; Karoly Szuhai; Jeroen Knijnenburg; Arko Gorter; Gemma G Kenter; Gert Jan Fleuren; Ekaterina S Jordanova
Journal:  BMC Genomics       Date:  2007-02-20       Impact factor: 3.969

Review 7.  Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis.

Authors:  Trung Vu; Pran K Datta
Journal:  Cancers (Basel)       Date:  2017-12-16       Impact factor: 6.639

Review 8.  TUSC3: a novel tumour suppressor gene and its functional implications.

Authors:  Xinshuang Yu; Chunjuan Zhai; Yujun Fan; Jiandong Zhang; Ning Liang; Fengjun Liu; Lili Cao; Jia Wang; Juan Du
Journal:  J Cell Mol Med       Date:  2017-03-08       Impact factor: 5.310

9.  Tumor suppressor candidate 3 as a novel predictor for lymph node metastasis in lung cancer patients.

Authors:  Xinshuang Yu; Kaixian Zhang; Fengjun Liu; Jiandong Zhang; Chunjuan Zhai; Lili Cao; Xingye Song; Yao Wang; Baosheng Li; Hongjun Sun; Juan Du
Journal:  Oncol Lett       Date:  2016-11-02       Impact factor: 2.967

10.  TUSC3 loss alters the ER stress response and accelerates prostate cancer growth in vivo.

Authors:  Peter Horak; Erwin Tomasich; Petr Vaňhara; Kateřina Kratochvílová; Mariam Anees; Maximilian Marhold; Christof E Lemberger; Marion Gerschpacher; Reinhard Horvat; Maria Sibilia; Dietmar Pils; Michael Krainer
Journal:  Sci Rep       Date:  2014-01-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.